1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. On the other hand, DexCom has attractive ...
Future Market Insights4d
Continuous Glucose Monitoring Systems Industry to Soar, Valued at USD 103.5 Billion by 2033 at a 25.1% of CAGR
The global continuous glucose monitoring (CGM) systems industry is poised for remarkable growth, surging from USD 11.1 ...
Glucose Monitors Are Finally Available Over the Counter
Over-the-counter continuous glucose monitors empower consumers with valuable health insights without the need for a doctor’s ...
Blood Glucose Monitoring Device Market Size to Accumulate Around USD 27.61 Billion by 2032, Growing at an 8.29% CAGR - SNS Insider
Driven by Rising Diabetes Prevalence, Aging Population, and Advancements in Monitoring Technologies, the Global Market Sees Rapid Growth with North America Leading and Asia-Pacific Emerging as the ...
pharmaphorum5d
Abbott’s OTC glucose monitor ‘will grow the market’
Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by the FDA, Abbott has got the green light for its Lingo device - and ...
Endocrinology Advisor1d
CGM Prescription Rates Low at Federally Qualified Health Centers
CGM prescription rates were low at federally qualified health centers, especially among patients without insurance and non-White patients.